{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:06Z","timestamp":1790712486056,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.colsurfb.2018.12.011","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:28:28Z","timestamp":1544102908000},"page":"523-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species"],"prefix":"10.1016","volume":"175","author":[{"given":"Mariana","family":"Domingues Bianchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Maria","family":"Borowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"da Rosa Monte Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Pippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Stanis\u00e7uaski Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-1807","authenticated-orcid":false,"given":"Adriana","family":"Raffin Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Meneghello Fuentefria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-7612","authenticated-orcid":false,"given":"Irene","family":"Clemes K\u00fclkamp-Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2018.12.011_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","article-title":"Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges","volume":"523","author":"Soliman","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0010","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IJN.S93105","article-title":"Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?","volume":"11","author":"Voltan","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/375806","article-title":"Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis","volume":"2012","author":"Nouraei","year":"2012","journal-title":"ISRN Obstet. Gynecol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinmicnews.2014.08.001","article-title":"Current epidemiology of Candida infection","volume":"36","author":"Lockhart","year":"2014","journal-title":"Clin. Microbiol. Newsl."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1439-0507.2011.02146.x","article-title":"Azole-resistant Candida spp. - emerging pathogens?","volume":"5","author":"Tobudic","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0035","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0040","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","author":"Healey","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/AAC.01095-08","article-title":"Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei","volume":"53","author":"Lamping","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1166\/jbn.2009.1004","article-title":"Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area","volume":"5","author":"J\u00e4ger","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0065","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1039\/c1sm05508a","article-title":"Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules","volume":"7","author":"Fiel","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0070","first-page":"1589","article-title":"Ketoconazole-loaded poly(\u03b5-Caprolactone) nanocapsules for improved antifungal activity against Candida spp","volume":"33","author":"Fuentefria","year":"2014","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2017.01.014","article-title":"Development and characterization of novel highly-loaded itraconazole poly(butyl cyanoacrylate) polymeric nanoparticles","volume":"114","author":"\u0106uri\u0107","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.colsurfb.2016.03.013","article-title":"Time to overcome fluconazole resistantCandida isolates: Solid lipidnanoparticles as a novel antifungal drug delivery system","volume":"142","author":"Moazeni","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2017.02.008","article-title":"Improved yeast delivery of fluconazole with a nanostructured lipid carrier system","volume":"89","author":"Kelidari","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0095","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard","author":"Clinical and laboratory standards institute (CLSI)","year":"2008"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0100","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement","author":"Clinical and laboratory standards institute (CLSI)","year":"2012"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/jam.12746","article-title":"In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp","volume":"118","author":"Pippi","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2016.07.018","article-title":"Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons","volume":"108","author":"Pardeike","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jddst.2017.05.020","article-title":"Assessing the performance of copaiba oil and allantoin nanoparticles on multidrug-resistant Candida parapsilosis","volume":"40","author":"Svetlichny","year":"2017","journal-title":"J Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001126","article-title":"Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi","volume":"6","author":"Mansfield","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0168-3659(02)00142-6","article-title":"Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(e-caprolactone) nanocapsule encapsulated form and as a digluconate","volume":"82","author":"Lboutounne","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jgar.2016.03.003","article-title":"Amino acid substitutions in Erg11p of azole-resistantCandida glabrata: possible effective substitutions and homology modelling","volume":"5","author":"Nabili","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0140","first-page":"273","article-title":"Expression patterns of abc transporter genes in fluconazole-resistant Candida glabrata","volume":"3-4","author":"Gohar","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chemphyslip.2012.01.006","article-title":"Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis","volume":"165","author":"Gupta","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0150","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874467210801020093","article-title":"Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies","volume":"1","author":"Wu","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0160","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AAC.44.6.1578-1584.2000","article-title":"Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750","volume":"44","author":"Barchiesi","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0165","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/np900177m","article-title":"Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp","volume":"72","author":"Digirolamo","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0170","first-page":"20","article-title":"Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida","volume":"9","author":"Sharma","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2012.09.016","article-title":"Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole","volume":"48","author":"Ahmad","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0180","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/AEM.02149-10","article-title":"Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni","volume":"77","author":"Xie","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0185","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/jam.12102","article-title":"Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms","volume":"114","author":"Monteiro","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2012.09.045","article-title":"Antifungal activity of transparent nanocomposite thin films of pullulan and silver against Aspergillus niger","volume":"103","author":"Pinto","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108876","article-title":"Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles","volume":"9","author":"Vazquez-Mu\u00f1oz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2018.12.011_bib0200","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/IJN.S13532","article-title":"Visualization of interaction between inorganic nanoparticles and bacteria or fungi","volume":"5","author":"Chwalibog","year":"2010","journal-title":"Int. J. Nanomed."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518308919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518308919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T20:21:23Z","timestamp":1549916483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776518308919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":40,"alternative-id":["S0927776518308919"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.12.011","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}